Alere Determine Combo HIV 1/2 Ag/Ab rapid test for HIV
Alere Australia has gained approval for the marketing in Australia of the Alere Determine Combo HIV 1/2 Ag/Ab rapid test for HIV. This marks the first approval for an innovative HIV assay to be included on the Australian Register of Therapeutic Goods (ARTG) for use in a point-of-care situation.
Marketing approval required lengthy scrutiny by the TGA of the scientific and clinical evidence supporting the test, including its accuracy when performed in near patient situations by healthcare professionals other than pathology laboratory scientists.
The point-of-care test offers significant benefits to patients and to healthcare workers in terms of convenience and rapid management of immediate clinical issues. It brings HIV testing technology right to the patient’s bedside.
Phone: 07 3363 7100
Navinci Diagnostics Naveni CD8/MHC-I Atto647N proximity ligation assay (PLA) kit
The Naveni CD8/MHC-I Atto647N is an in situ proximity ligation assay kit for the detection of the...
Invent Biotechnologies Minute Single Cell Nuclei Kits
The Invent Biotechnologies Minute Single Cell Nuclei Kits use proprietary spin column-based...
MP Biomedicals MagBeads FastDNA MaxPure Kit for Feces and Fecal Preservation Solution
MP Biomedicals MagBeads FastDNA MaxPure Kit for Feces is a magnetic bead-based solution...
